Mirati Therapeutics, Inc. logo

Mirati Therapeutics, Inc.

34 Marks
Corp.
First Filed:Aug 11, 2014Latest Filed:Apr 5, 2023Address:3545 Cray Court, San Diego, CA 92121

Portfolio Overview

Registered
19(56%)
Pending
5(15%)
Dead
10(29%)

Top Classes

Class 5
Pharmaceuticals
25(74%)
Class 42
Software, IT Services & Scientific Research
11(32%)
Class 44
Medical, beauty and agricultural services
2(6%)

TTAB Proceedings

No litigation activity

Top Firms

BRISTOL-MYERS SQUIBB COMPANY(Apr 2023)
25
McDonnell Boehnen Hulbert & ...(Dec 2021)
8

Trademark Activity Timeline(2014 – 2023)

Trademark Portfolio

34 results

(current & previous marks)

Refine by Mark/Description🔽
Filed
Registered
Last Activity
STRA
STRA
Trademark
Word
ABANDONED
Owner:
Serial:97874809
Filed:Apr 5, 2023
Classes:5
MTYKA
MTYKA
Trademark
Word
PENDING
Owner:
Serial:97661691
Filed:Nov 3, 2022
Classes:5, 42
Goods & Services
Pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for use in oncology; pharmaceutical preparations for the treatment of infectious diseases; pharmaceutical preparations for the treatment of bladder cancer; pharmaceutical preparations for the treatment of lung cancer; pharmaceutical preparations for the treatment of renal cancer; pharmaceutical preparations for the treatment of renal cell carcinoma; pharmaceutical preparations for the treatment of squamous cell carcinoma; pharmaceutical preparations for the treatment of head and neck squamous cell carcinoma; pharmaceutical preparations for the treatment of oral cavity squamous cell carcinoma; pharmaceutical preparations for the treatment of colorectal cancer; pharmaceuticals comprising small molecules for the treatment of cancer; pharmaceuticals comprising small molecules for the treatment of bladder cancer; pharmaceuticals comprising small molecules for the treatment of lung cancer; pharmaceuticals comprising small molecules for the treatment of renal cancer; pharmaceuticals comprising small molecules for the treatment of renal cell carcinoma; pharmaceuticals comprising small molecules for the treatment of squamous cell carcinoma; pharmaceuticals comprising small molecules for the treatment of head and neck squamous cell carcinoma; pharmaceuticals comprising small molecules for the treatment of oral cavity squamous cell carcinoma; pharmaceuticals comprising small molecules for the treatment of colorectal cancer; pharmaceutical products for the treatment of cancer; pharmaceutical products for use in oncology; pharmaceutical products for the treatment of infectious diseases; pharmaceutical products for the treatment of bladder cancer; pharmaceutical products for the treatment of lung cancer; pharmaceutical products for the treatment of renal cancer; pharmaceutical products for the treatment of renal cell carcinoma; pharmaceutical products for the treatment of squamous cell carcinoma; pharmaceutical products for the treatment of head and neck squamous cell carcinoma; pharmaceutical products for the treatment of oral cavity squamous cell carcinoma; pharmaceutical products for the treatment of colorectal cancer; pharmaceuticals comprising compounds for the treatment of cancer; pharmaceuticals comprising inhibitors for the treatment of cancer; pharmaceuticals for the treatment of solid tumors; Research and development of pharmaceuticals in the field of oncology; providing information in the field of scientific and medical research related to oncology; research and development of pharmaceuticals; providing information in the field of scientific and medical research related to pharmaceuticals
LIFTYKA
LIFTYKA
Trademark
Word
PENDING
Owner:
Serial:97561020
Filed:Aug 23, 2022
Classes:5, 42
Goods & Services
Pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for use in oncology; pharmaceutical preparations for the treatment of infectious diseases; pharmaceutical preparations for the treatment of bladder cancer; pharmaceutical preparations for the treatment of lung cancer; pharmaceutical preparations for the treatment of renal cancer; pharmaceutical preparations for the treatment of renal cell carcinoma; pharmaceutical preparations for the treatment of squamous cell carcinoma; pharmaceutical preparations for the treatment of head and neck squamous cell carcinoma; pharmaceutical preparations for the treatment of oral cavity squamous cell carcinoma; pharmaceutical preparations for the treatment of colorectal cancer; pharmaceuticals comprising small molecules for the treatment of cancer; pharmaceuticals comprising small molecules for the treatment of bladder cancer; pharmaceuticals comprising small molecules for the treatment of lung cancer; pharmaceuticals comprising small molecules for the treatment of renal cancer; pharmaceuticals comprising small molecules for the treatment of renal cell carcinoma; pharmaceuticals comprising small molecules for the treatment of squamous cell carcinoma; pharmaceuticals comprising small molecules for the treatment of head and neck squamous cell carcinoma; pharmaceuticals comprising small molecules for the treatment of oral cavity squamous cell carcinoma; pharmaceuticals comprising small molecules for the treatment of colorectal cancer; pharmaceutical products for the treatment of cancer; pharmaceutical products for use in oncology; pharmaceutical products for the treatment of infectious diseases; pharmaceutical products for the treatment of bladder cancer; pharmaceutical products for the treatment of lung cancer; pharmaceutical products for the treatment of renal cancer; pharmaceutical products for the treatment of renal cell carcinoma; pharmaceutical products for the treatment of squamous cell carcinoma; pharmaceutical products for the treatment of head and neck squamous cell carcinoma; pharmaceutical products for the treatment of oral cavity squamous cell carcinoma; pharmaceutical products for the treatment of colorectal cancer; pharmaceuticals comprising compounds for the treatment of cancer; pharmaceuticals comprising inhibitors for the treatment of cancer; pharmaceuticals for the treatment of solid tumors; Research and development of pharmaceuticals in the field of oncology; providing information in the field of scientific and medical research related to oncology; research and development of pharmaceuticals; providing information in the field of scientific and medical research related to pharmaceuticals
MAVTYKA
MAVTYKA
Trademark
Word
PENDING
Owner:
Serial:97561008
Filed:Aug 23, 2022
Classes:5, 42
Goods & Services
Pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for use in oncology; pharmaceutical preparations for the treatment of infectious diseases; pharmaceutical preparations for the treatment of bladder cancer; pharmaceutical preparations for the treatment of lung cancer; pharmaceutical preparations for the treatment of renal cancer; pharmaceutical preparations for the treatment of renal cell carcinoma; pharmaceutical preparations for the treatment of squamous cell carcinoma; pharmaceutical preparations for the treatment of head and neck squamous cell carcinoma; pharmaceutical preparations for the treatment of oral cavity squamous cell carcinoma; pharmaceutical preparations for the treatment of colorectal cancer; pharmaceuticals comprising small molecules for the treatment of cancer; pharmaceuticals comprising small molecules for the treatment of bladder cancer; pharmaceuticals comprising small molecules for the treatment of lung cancer; pharmaceuticals comprising small molecules for the treatment of renal cancer; pharmaceuticals comprising small molecules for the treatment of renal cell carcinoma; pharmaceuticals comprising small molecules for the treatment of squamous cell carcinoma; pharmaceuticals comprising small molecules for the treatment of head and neck squamous cell carcinoma; pharmaceuticals comprising small molecules for the treatment of oral cavity squamous cell carcinoma; pharmaceuticals comprising small molecules for the treatment of colorectal cancer; pharmaceutical products for the treatment of cancer; pharmaceutical products for use in oncology; pharmaceutical products for the treatment of infectious diseases; pharmaceutical products for the treatment of bladder cancer; pharmaceutical products for the treatment of lung cancer; pharmaceutical products for the treatment of renal cancer; pharmaceutical products for the treatment of renal cell carcinoma; pharmaceutical products for the treatment of squamous cell carcinoma; pharmaceutical products for the treatment of head and neck squamous cell carcinoma; pharmaceutical products for the treatment of oral cavity squamous cell carcinoma; pharmaceutical products for the treatment of colorectal cancer; pharmaceuticals comprising compounds for the treatment of cancer; pharmaceuticals comprising inhibitors for the treatment of cancer; pharmaceuticals for the treatment of solid tumors; Research and development of pharmaceuticals in the field of oncology; providing information in the field of scientific and medical research related to oncology; research and development of pharmaceuticals; providing information in the field of scientific and medical research related to pharmaceuticals
KRAZATI
KRAZATI
Trademark
Stylized
REGISTERED
Owner:
Serial:97541672
Filed:Aug 9, 2022
Classes:5
Registration:7159330
Registered:Sep 5, 2023
Goods & Services
pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for use in oncology; pharmaceutical preparations for the treatment of lung cancer; pharmaceutical preparations for the treatment of non-small cell lung carcinoma; pharmaceuticals comprising small molecules for the treatment of cancer; pharmaceuticals comprising small molecules for the treatment of lung cancer; pharmaceuticals comprising small molecules for the treatment of non-small cell lung carcinoma; pharmaceuticals comprising compounds for the treatment of cancer; pharmaceuticals comprising inhibitors for the treatment of cancer; pharmaceuticals for the treatment of solid tumors; pharmaceuticals for the treatment of advanced solid tumors
KRAZATI
KRAZATI
Trademark
Stylized
REGISTERED
Owner:
Serial:97541653
Filed:Aug 9, 2022
Classes:5
Registration:7159329
Registered:Sep 5, 2023
Goods & Services
pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for use in oncology; pharmaceutical preparations for the treatment of lung cancer; pharmaceutical preparations for the treatment of non-small cell lung carcinoma; pharmaceuticals comprising small molecules for the treatment of cancer; pharmaceuticals comprising small molecules for the treatment of lung cancer; pharmaceuticals comprising small molecules for the treatment of non-small cell lung carcinoma; pharmaceuticals comprising compounds for the treatment of cancer; pharmaceuticals comprising inhibitors for the treatment of cancer; pharmaceuticals for the treatment of solid tumors; pharmaceuticals for the treatment of advanced solid tumors | research and development of pharmaceuticals in the field of oncology; providing information in the field of scientific and medical research related to oncology; research and development of pharmaceuticals; providing information in the field of scientific and medical research related to pharmaceuticals
KRAZATI
KRAZATI
Trademark
Stylized
REGISTERED
Owner:
Serial:97541596
Filed:Aug 9, 2022
Classes:5
Registration:7159328
Registered:Sep 5, 2023
Goods & Services
pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for use in oncology; pharmaceutical preparations for the treatment of lung cancer; pharmaceutical preparations for the treatment of non-small cell lung carcinoma; pharmaceuticals comprising small molecules for the treatment of cancer; pharmaceuticals comprising small molecules for the treatment of lung cancer; pharmaceuticals comprising small molecules for the treatment of non-small cell lung carcinoma; pharmaceuticals comprising compounds for the treatment of cancer; pharmaceuticals comprising inhibitors for the treatment of cancer; pharmaceuticals for the treatment of solid tumors; pharmaceuticals for the treatment of advanced solid tumors | research and development of pharmaceuticals in the field of oncology; providing information in the field of scientific and medical research related to oncology; research and development of pharmaceuticals; providing information in the field of scientific and medical research related to pharmaceuticals
KRAZATI
KRAZATI
Service Mark
Stylized
REGISTERED
Owner:
Serial:97541729
Filed:Aug 9, 2022
Classes:42
Registration:7027981
Registered:Apr 11, 2023
Goods & Services
research and development of pharmaceuticals in the field of oncology; providing information in the field of scientific and medical research related to oncology; research and development of pharmaceuticals; providing information in the field of scientific and medical research related to pharmaceuticals
KRAZATI
KRAZATI
Trademark
Stylized
REGISTERED
Owner:
Serial:97541713
Filed:Aug 9, 2022
Classes:5
Registration:7159331
Registered:Sep 5, 2023
Goods & Services
pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for use in oncology; pharmaceutical preparations for the treatment of infectious diseases; pharmaceutical preparations for the treatment of lung cancer; pharmaceutical preparations for the treatment of non-small cell lung carcinoma; pharmaceutical preparations for the treatment of colorectal carcinoma; pharmaceutical preparations for the treatment of pancreatic cancer; pharmaceuticals comprising small molecules for the treatment of cancer; pharmaceuticals comprising small molecules for the treatment of infectious diseases; pharmaceuticals comprising small molecules for the treatment of lung cancer; pharmaceuticals comprising small molecules for the treatment of non-small cell lung carcinoma; pharmaceuticals comprising small molecules for the treatment of colorectal carcinoma; pharmaceuticals comprising small molecules for the treatment of pancreatic cancer; pharmaceuticals comprising compounds for the treatment of cancer; pharmaceuticals comprising inhibitors for the treatment of cancer; pharmaceuticals for the treatment of solid tumors; pharmaceuticals for the treatment of advanced solid tumors
KRAZATI
KRAZATI
Service Mark
Stylized
REGISTERED
Owner:
Serial:97541695
Filed:Aug 9, 2022
Classes:42
Registration:7020760
Registered:Apr 4, 2023
Goods & Services
research and development of pharmaceuticals in the field of oncology; providing information in the field of scientific and medical research related to oncology; research and development of pharmaceuticals; providing information in the field of scientific and medical research related to pharmaceuticals
MMX
MMX
Trademark
Stylized
REGISTERED
Owner:
Serial:97481214
Filed:Jun 29, 2022
Classes:9
Registration:7159306
Registered:Sep 5, 2023
Goods & Services
Downloadable computer software for use in customer relationship management (CRM); Downloadable enterprise software for customer relationship management; Downloadable computer software and downloadable mobile application software for the access, management, organization, collaboration, and sharing of content, communications, electronic data, and information in the fields of customer relationship management (CRM); downloadable computer software and downloadable mobile application software for document management; downloadable computer software and downloadable mobile application software for the collection, editing, managing, organizing, modifying, bookmarking, transmission storage and sharing of data and information
MTYEKA
MTYEKA
Trademark
Word
PENDING
Owner:
Serial:97301650
Filed:Mar 8, 2022
Classes:5, 42
Goods & Services
pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for use in oncology; pharmaceutical preparations for the treatment of infectious diseases; pharmaceutical preparations for the treatment of bladder cancer; pharmaceutical preparations for the treatment of lung cancer; pharmaceutical preparations for the treatment of renal cancer; pharmaceutical preparations for the treatment of renal cell carcinoma; pharmaceutical preparations for the treatment of squamous cell carcinoma; pharmaceutical preparations for the treatment of head and neck squamous cell carcinoma; pharmaceutical preparations for the treatment of oral cavity squamous cell carcinoma; pharmaceutical preparations for the treatment of colorectal cancer; pharmaceuticals comprising small molecules for the treatment of cancer; pharmaceuticals comprising small molecules for the treatment of bladder cancer; pharmaceuticals comprising small molecules for the treatment of lung cancer; pharmaceuticals comprising small molecules for the treatment of renal cancer; pharmaceuticals comprising small molecules for the treatment of renal cell carcinoma; pharmaceuticals comprising small molecules for the treatment of squamous cell carcinoma; pharmaceuticals comprising small molecules for the treatment of head and neck squamous cell carcinoma; pharmaceuticals comprising small molecules for the treatment of oral cavity squamous cell carcinoma; pharmaceuticals comprising small molecules for the treatment of colorectal cancer; pharmaceutical products for the treatment of cancer; pharmaceutical products for use in oncology; pharmaceutical products for the treatment of infectious diseases; pharmaceutical products for the treatment of bladder cancer; pharmaceutical products for the treatment of lung cancer; pharmaceutical products for the treatment of renal cancer; pharmaceutical products for the treatment of renal cell carcinoma; pharmaceutical products for the treatment of squamous cell carcinoma; pharmaceutical products for the treatment of head and neck squamous cell carcinoma; pharmaceutical products for the treatment of oral cavity squamous cell carcinoma; pharmaceutical products for the treatment of colorectal cancer; pharmaceuticals comprising compounds for the treatment of cancer; pharmaceuticals comprising inhibitors for the treatment of cancer; pharmaceuticals for the treatment of solid tumors; research and development of pharmaceuticals in the field of oncology; providing information in the field of scientific and medical research related to oncology; research and development of pharmaceuticals; providing information in the field of scientific and medical research related to pharmaceuticals
MTYKEA
MTYKEA
Trademark
Word
PENDING
Owner:
Serial:97301667
Filed:Mar 8, 2022
Classes:5, 42
Goods & Services
pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for use in oncology; pharmaceutical preparations for the treatment of infectious diseases; pharmaceutical preparations for the treatment of bladder cancer; pharmaceutical preparations for the treatment of lung cancer; pharmaceutical preparations for the treatment of renal cancer; pharmaceutical preparations for the treatment of renal cell carcinoma; pharmaceutical preparations for the treatment of squamous cell carcinoma; pharmaceutical preparations for the treatment of head and neck squamous cell carcinoma; pharmaceutical preparations for the treatment of oral cavity squamous cell carcinoma; pharmaceutical preparations for the treatment of colorectal cancer; pharmaceuticals comprising small molecules for the treatment of cancer; pharmaceuticals comprising small molecules for the treatment of bladder cancer; pharmaceuticals comprising small molecules for the treatment of lung cancer; pharmaceuticals comprising small molecules for the treatment of renal cancer; pharmaceuticals comprising small molecules for the treatment of renal cell carcinoma; pharmaceuticals comprising small molecules for the treatment of squamous cell carcinoma; pharmaceuticals comprising small molecules for the treatment of head and neck squamous cell carcinoma; pharmaceuticals comprising small molecules for the treatment of oral cavity squamous cell carcinoma; pharmaceuticals comprising small molecules for the treatment of colorectal cancer; pharmaceutical products for the treatment of cancer; pharmaceutical products for use in oncology; pharmaceutical products for the treatment of infectious diseases; pharmaceutical products for the treatment of bladder cancer; pharmaceutical products for the treatment of lung cancer; pharmaceutical products for the treatment of renal cancer; pharmaceutical products for the treatment of renal cell carcinoma; pharmaceutical products for the treatment of squamous cell carcinoma; pharmaceutical products for the treatment of head and neck squamous cell carcinoma; pharmaceutical products for the treatment of oral cavity squamous cell carcinoma; pharmaceutical products for the treatment of colorectal cancer; pharmaceuticals comprising compounds for the treatment of cancer; pharmaceuticals comprising inhibitors for the treatment of cancer; pharmaceuticals for the treatment of solid tumors; research and development of pharmaceuticals in the field of oncology; providing information in the field of scientific and medical research related to oncology; research and development of pharmaceuticals; providing information in the field of scientific and medical research related to pharmaceuticals
MIRATI & ME
MIRATI & ME
Service Mark
Combined
REGISTERED
Owner:
Serial:97240153
Filed:Jan 26, 2022
Classes:44
Registration:7158866
Registered:Sep 5, 2023
Goods & Services
Providing personal support services for families of patients with life threatening disorders, namely, counseling in the field of healthcare insurance benefits | Charitable services, namely, patient assistance program to provide drugs free of charge to low-income patients without sufficient prescription drug coverage; Dispensing of pharmaceuticals; Individual medical counseling services provided to patients; Medical and pharmaceutical consultation; Pharmaceutical advice; Providing information to patients in the field of administering medications; Providing personal support services for families of patients with life threatening disorders, namely, psychological counseling and health counseling services | Consulting services, namely, conducting insurance benefit investigations for pharmaceutical and biotechnology companies; Providing patient advocate and case management services, namely, coordinating the procurement and administration of medication; Providing patient advocate services in the field of cancer treatment; Providing personal support services for families of patients with life threatening disorders, namely, companionship, help with medical forms, emotional counseling and emotional support; Providing personal support services for patients and families of patients with cancer, namely, emotional counseling and emotional support; Providing personal support services for patients and families of patients, namely, emotional counseling and emotional support
MIRATI & ME
MIRATI & ME
Service Mark
Word
REGISTERED
Owner:
Serial:97240198
Filed:Jan 26, 2022
Classes:44
Registration:7158867
Registered:Sep 5, 2023
Goods & Services
Providing personal support services for families of patients with life threatening disorders, namely, counseling in the field of healthcare insurance benefits | Charitable services, namely, patient assistance program to provide drugs free of charge to low-income patients without sufficient prescription drug coverage; Dispensing of pharmaceuticals; Individual medical counseling services provided to patients; Medical and pharmaceutical consultation; Pharmaceutical advice; Providing information to patients in the field of administering medications; Providing personal support services for families of patients with life threatening disorders, namely, psychological counseling and health counseling services | Consulting services, namely, conducting insurance benefit investigations for pharmaceutical and biotechnology companies; Providing patient advocate and case management services, namely, coordinating the procurement and administration of medication; Providing patient advocate services in the field of cancer treatment; Providing personal support services for families of patients with life threatening disorders, namely, companionship, help with medical forms, emotional counseling and emotional support; Providing personal support services for patients and families of patients with cancer, namely, emotional counseling and emotional support; Providing personal support services for patients and families of patients, namely, emotional counseling and emotional support
KRAZELVI
KRAZELVI
Trademark
Word
ABANDONED
Owner:
Serial:97191230
Filed:Dec 27, 2021
Classes:5
M
M
Trademark
Stylized
REGISTERED
Owner:
Serial:97037315
Filed:Sep 21, 2021
Classes:5
Registration:7020386
Registered:Apr 4, 2023
Goods & Services
pharmaceutical preparations for the prevention and/or treatment of cancer; pharmaceutical preparations for use in oncology
MIRATI
MIRATI
Trademark
Word
REGISTERED
Owner:
Serial:90796207
Filed:Jun 25, 2021
Classes:5
Registration:7164949
Registered:Sep 12, 2023
Goods & Services
pharmaceutical preparations for the prevention and/or treatment of cancer; pharmaceutical preparations for use in oncology
M
M
Service Mark
Stylized
REGISTERED
Owner:
Serial:90739463
Filed:May 27, 2021
Classes:42
Registration:6659596
Registered:Mar 1, 2022
Goods & Services
research and development of pharmaceuticals in the field of oncology; providing information in the field of scientific and medical research related to oncology; research and development of pharmaceuticals; providing information in the field of scientific and medical research related to pharmaceuticals
M
M
Trademark
Stylized
REGISTERED
Owner:
Serial:90739406
Filed:May 27, 2021
Classes:5
Registration:7019941
Registered:Apr 4, 2023
Goods & Services
pharmaceutical preparations for the prevention and/or treatment of cancer; pharmaceutical preparations for use in oncology
MIRATI
MIRATI
Trademark
Stylized
REGISTERED
Owner:
Serial:90739492
Filed:May 27, 2021
Classes:5
Registration:7019942
Registered:Apr 4, 2023
Goods & Services
pharmaceutical preparations for the prevention and/or treatment of cancer; pharmaceutical preparations for use in oncology
MIRATI
MIRATI
Service Mark
Stylized
REGISTERED
Owner:
Serial:90739531
Filed:May 27, 2021
Classes:42
Registration:6659597
Registered:Mar 1, 2022
Goods & Services
research and development of pharmaceuticals in the field of oncology; providing information in the field of scientific and medical research related to oncology; research and development of pharmaceuticals; providing information in the field of scientific and medical research related to pharmaceuticals
MIRATI THERAPEUTICS
MIRATI THERAPEUTICS
Trademark
Stylized
REGISTERED
Owner:
Serial:90739552
Filed:May 27, 2021
Classes:5
Registration:7019943
Registered:Apr 4, 2023
Goods & Services
Class 005: pharmaceutical preparations for the prevention and/or treatment of cancer; pharmaceutical preparations for use in oncology
MIRATI THERAPEUTICS
MIRATI THERAPEUTICS
Service Mark
Stylized
REGISTERED
Owner:
Serial:90739574
Filed:May 27, 2021
Classes:42
Registration:6713167
Registered:Apr 26, 2022
Goods & Services
Class 042: research and development of pharmaceuticals in the field of oncology; providing information in the field of scientific and medical research related to oncology; research and development of pharmaceuticals; providing information in the field of scientific and medical research related to pharmaceuticals
BYKRASO
BYKRASO
Trademark
Word
ABANDONED
Owner:
Serial:90603920
Filed:Mar 25, 2021
Classes:5
KRAZATI
KRAZATI
Trademark
Word
REGISTERED
Owner:
Serial:90603915
Filed:Mar 25, 2021
Classes:5
Registration:7019779
Registered:Apr 4, 2023
Goods & Services
pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for use in oncology; pharmaceutical preparations for the treatment of infectious diseases; pharmaceutical preparations for the treatment of lung cancer; pharmaceutical preparations for the treatment of non-small cell lung carcinoma; pharmaceutical preparations for the treatment of colorectal carcinoma; pharmaceutical preparations for the treatment of pancreatic cancer; pharmaceuticals comprising small molecules for the treatment of cancer; pharmaceuticals comprising small molecules for the treatment of infectious diseases; pharmaceuticals comprising small molecules for the treatment of lung cancer; pharmaceuticals comprising small molecules for the treatment of non-small cell lung carcinoma; pharmaceuticals comprising small molecules for the treatment of colorectal carcinoma; pharmaceuticals comprising small molecules for the treatment of pancreatic cancer; pharmaceuticals comprising compounds for the treatment of cancer; pharmaceuticals comprising inhibitors for the treatment of cancer; pharmaceuticals for the treatment of solid tumors; pharmaceuticals for the treatment of advanced solid tumors | research and development of pharmaceuticals in the field of oncology; providing information in the field of scientific and medical research related to oncology; research and development of pharmaceuticals; providing information in the field of scientific and medical research related to pharmaceuticals
KRASLOQ
KRASLOQ
Trademark
Word
ABANDONED
Owner:
Serial:90238399
Filed:Oct 6, 2020
Classes:5
MTAMRIO
MTAMRIO
Trademark
Word
ABANDONED
Owner:
Serial:88408993
Filed:Apr 30, 2019
Classes:5
MTARGIO
MTARGIO
Trademark
Word
ABANDONED
Owner:
Serial:88408985
Filed:Apr 30, 2019
Classes:5
MTYKA
MTYKA
Trademark
Word
ABANDONED
Owner:
Serial:88409002
Filed:Apr 30, 2019
Classes:5
VYMIRIO
VYMIRIO
Trademark
Word
ABANDONED
Owner:
Serial:88408998
Filed:Apr 30, 2019
Classes:5
MIRATI
MIRATI
Trademark
Word
ABANDONED
Owner:
Serial:87827891
Filed:Mar 9, 2018
Classes:5
MIRATI
MIRATI
Service Mark
Word
REGISTERED
Owner:
Serial:86363098
Filed:Aug 11, 2014
Classes:42
Registration:4712007
Registered:Mar 31, 2015
Goods & Services
research and development of pharmaceuticals in the field of oncology; providing information in the field of scientific and medical research related to oncology
MIRATI
MIRATI
Trademark
Word
ABANDONED
Owner:
Serial:86363091
Filed:Aug 11, 2014
Classes:5

Cookie Preferences

We use cookies (including Google Analytics) to improve our site and understand how visitors use it.